Bellevue Life Sciences Acquisition (BLAC) Competitors $1.02 -0.01 (-0.97%) As of 07/23/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock BLAC vs. PETV, NXGL, IINN, NRXS, IRIX, NXL, PSTV, INBS, XAIR, and MHUAShould you be buying Bellevue Life Sciences Acquisition stock or one of its competitors? The main competitors of Bellevue Life Sciences Acquisition include PetVivo (PETV), NexGel (NXGL), Inspira Technologies OXY B.H.N. (IINN), NeurAxis (NRXS), IRIDEX (IRIX), Nexalin Technology (NXL), Plus Therapeutics (PSTV), Intelligent Bio Solutions (INBS), Beyond Air (XAIR), and Meihua International Medical Technologies (MHUA). These companies are all part of the "medical equipment" industry. Bellevue Life Sciences Acquisition vs. Its Competitors PetVivo NexGel Inspira Technologies OXY B.H.N. NeurAxis IRIDEX Nexalin Technology Plus Therapeutics Intelligent Bio Solutions Beyond Air Meihua International Medical Technologies PetVivo (NASDAQ:PETV) and Bellevue Life Sciences Acquisition (NASDAQ:BLAC) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, profitability, dividends, valuation, analyst recommendations, earnings and media sentiment. Do institutionals & insiders hold more shares of PETV or BLAC? 24.5% of PetVivo shares are held by institutional investors. Comparatively, 55.3% of Bellevue Life Sciences Acquisition shares are held by institutional investors. 10.8% of PetVivo shares are held by company insiders. Comparatively, 33.7% of Bellevue Life Sciences Acquisition shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Is PETV or BLAC more profitable? Bellevue Life Sciences Acquisition has a net margin of 0.00% compared to PetVivo's net margin of -902.82%. Bellevue Life Sciences Acquisition's return on equity of 0.00% beat PetVivo's return on equity.Company Net Margins Return on Equity Return on Assets PetVivo-902.82% -4,813.07% -281.78% Bellevue Life Sciences Acquisition N/A N/A N/A Which has better earnings and valuation, PETV or BLAC? Bellevue Life Sciences Acquisition has lower revenue, but higher earnings than PetVivo. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPetVivo$1.05M18.72-$10.95M-$0.42-1.90Bellevue Life Sciences AcquisitionN/AN/AN/AN/AN/A Which has more volatility & risk, PETV or BLAC? PetVivo has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500. Comparatively, Bellevue Life Sciences Acquisition has a beta of -0.08, suggesting that its stock price is 108% less volatile than the S&P 500. Does the media prefer PETV or BLAC? In the previous week, PetVivo had 1 more articles in the media than Bellevue Life Sciences Acquisition. MarketBeat recorded 1 mentions for PetVivo and 0 mentions for Bellevue Life Sciences Acquisition. PetVivo's average media sentiment score of 0.67 beat Bellevue Life Sciences Acquisition's score of 0.00 indicating that PetVivo is being referred to more favorably in the media. Company Overall Sentiment PetVivo Positive Bellevue Life Sciences Acquisition Neutral SummaryBellevue Life Sciences Acquisition beats PetVivo on 5 of the 9 factors compared between the two stocks. Get Bellevue Life Sciences Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for BLAC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BLAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLAC vs. The Competition Export to ExcelMetricBellevue Life Sciences AcquisitionHolding Offices IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$4.12M$209.87M$2.18B$9.51BDividend YieldN/A3.22%2.57%3.99%P/E RatioN/A1.8822.1420.03Price / SalesN/A585.7590.60103.88Price / CashN/A109.2828.9259.01Price / BookN/A9.3759.775.90Net IncomeN/A-$10.64M-$121.56M$258.66M7 Day Performance2.00%0.07%0.91%2.23%1 Month Performance-20.31%0.03%2.65%12.77%1 Year Performance-90.58%111.47%25.96%19.36% Bellevue Life Sciences Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLACBellevue Life Sciences AcquisitionN/A$1.02-1.0%N/A-90.6%$4.12MN/A0.00N/AHigh Trading VolumePETVPetVivoN/A$0.78-0.3%N/A+29.1%$18.98M$1.05M-1.7420NXGLNexGel0.8632 of 5 stars$2.38-5.4%N/A-15.9%$18.15M$8.69M-5.2710IINNInspira Technologies OXY B.H.N.2.2303 of 5 stars$1.40+4.4%$2.00+43.0%+31.2%$17.61MN/A0.0020NRXSNeurAxis2.4601 of 5 stars$2.42-1.6%$7.00+189.1%-14.6%$17.47M$2.93M-1.3219IRIXIRIDEX0.9196 of 5 stars$1.03+3.0%N/A-34.0%$17.29M$48.67M-2.40120Gap UpNXLNexalin Technology3.0259 of 5 stars$1.00-2.0%$5.00+400.0%+0.8%$17.18M$170K-1.203Positive NewsPSTVPlus Therapeutics1.624 of 5 stars$0.33+3.2%$10.83+3,212.9%-65.9%$16.73MN/A-0.1120INBSIntelligent Bio Solutions1.0447 of 5 stars$2.08+9.2%N/A+28.4%$14.34M$3.11M0.0010Positive NewsGap UpXAIRBeyond Air4.5519 of 5 stars$3.23+2.2%$30.00+828.8%-71.3%$13.95M$3.71M-0.2070MHUAMeihua International Medical Technologies0.9687 of 5 stars$0.43-2.3%N/A-62.3%$13.62M$96.90M0.00620 Related Companies and Tools Related Companies PETV Competitors NXGL Competitors IINN Competitors NRXS Competitors IRIX Competitors NXL Competitors PSTV Competitors INBS Competitors XAIR Competitors MHUA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BLAC) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellevue Life Sciences Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bellevue Life Sciences Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BLAC Stock Alerts